Skip to main content
SpringerLink
Log in

Dialysis independence following single-agent daratumumab in refractory myeloma with renal failure

  • Letter to the Editor
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Evison F, Sangha J, Yadav P, Aung YS, Sharif A, Pinney JA, Drayson MT, Cook M, Cockwell P (2018) A population-based study of the impact of dialysis on mortality in multiple myeloma. Br J Haematol 180(4):588–591 https://www.ncbi.nlm.nih.gov/pubmed/27766629

    Article  PubMed  Google Scholar 

  2. Haynes RJ, Read S, Collins GP, Darby SC, Winearls CG (2010) Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre. Nephrol Dial Transplant 25(2):419–426 https://www.ncbi.nlm.nih.gov/pubmed/19767634

    Article  PubMed  Google Scholar 

  3. Hutchison CA, Cockwell P, Stringer S, Bradwell A, Cook M, Gertz MA, Dispenzieri A, Winters JL, Kumar S, Rajkumar SV, Kyle RA, Leung N (2011) Early reduction of serum-free light chains associates with renal recovery in myeloma kidney. J Am Soc Nephrol 22(6):1129–1136 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103732/

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Yadav P, Hutchison CA, Basnayake K et al (2016) Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysis-dependent acute kidney injury. Eur J Haematol 96(6):610–617 https://www.ncbi.nlm.nih.gov/pubmed/26248588

    Article  PubMed  Google Scholar 

  5. Lokhorst HM, Plesner T, Laubach JP et al (2015) Targeting CD38 with daratumumab monotherapy in multiple myeloma. N Engl J Med 373(13):1207–1219 https://www.ncbi.nlm.nih.gov/pubmed/26308596

    Article  CAS  PubMed  Google Scholar 

  6. Rocchi S, Tacchetti P, Pantani L, Mancuso K, Zannetti B, Cavo M, Zamagni E (2018) Safety and efficacy of daratumumab in dialysis-dependent renal failure secondary to multiple myeloma. Haematologica 103(6):e277–e278 https://www.ncbi.nlm.nih.gov/pubmed/29622654

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Dimopoulos MA, Roussou M, Gavriatopoulou M et al (2017) Outcomes of newly diagnosed myeloma patients requiring dialysis: renal recovery, importance of rapid response and survival benefit. Blood Cancer J 16(7):6 https://www.ncbi.nlm.nih.gov/pubmed/28622304

    Google Scholar 

  8. Dimopoulos M, Weisel K, van de Donck NWJC et al (2018) Pomalidomide plus low-dose dexamethasone in patients with Relapsed/refractory multiple myeloma and renal impairment: results from a phase II trial. J Clin Oncol 36(20):2035–2043 https://www.ncbi.nlm.nih.gov/pubmed/29394124

    Article  CAS  PubMed  Google Scholar 

  9. Chanan-Khan AA, Kaufman JL, Mehta J et al (2007) Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study. Blood 109(6):2604–2606 https://www.ncbi.nlm.nih.gov/pubmed/17138816

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Haematology, Beaumont Hospital, Dublin 9, Beaumont, Ireland

    Elizabeth Smyth, Siobhan Glavey, Dario Melotti, Patrick Thornton, Jeremy Sargent, Philip Murphy & John Quinn

  2. Department of Nephrology, Beaumont Hospital, Dublin 9, Beaumont, Ireland

    Peter Conlon

Authors
  1. Elizabeth Smyth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Siobhan Glavey
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dario Melotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Patrick Thornton
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jeremy Sargent
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Peter Conlon
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Philip Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. John Quinn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John Quinn.

Ethics declarations

Informed consent

The patient gave informed consent for this letter to be written.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Smyth, E., Glavey, S., Melotti, D. et al. Dialysis independence following single-agent daratumumab in refractory myeloma with renal failure. Ir J Med Sci 188, 1079–1080 (2019). https://doi.org/10.1007/s11845-018-1951-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-018-1951-6

Keywords

Search

Navigation